OPYS Telehealth Blog Series January 6, 2022 Issue No. 2 Anytime you hear or read a healthcare related news story, there seems to be more information about COVID, and the global pandemic that is now approaching the two-year mark. The newest variant gaining traction is called flurona.[1] As you might guess, the term flurona is used when a … [Read more...]
Expanding Telehealth Access – Lessons from Omicron
What are the Data on Ivermectin for COVID-19?
Ivermectin, a medication that has long been approved by the U.S. Food and Drug Administration (FDA) and World Health Organization (WHO) to fight parasites and treat worm infections, has been a topic of controversy during the COVID-19 pandemic. Some experts have argued that public messages about ivermectin could lead people to use ivermectin that is … [Read more...]
Do Financial Incentives Motivate People to Get the COVID-19 Vaccine?
Since the vaccines against COVID-19 were in development, physicians and other healthcare experts recognized that the rollout of the vaccines would likely be met with vaccine hesitancy. While the world has contended with a group of people who are opposed to any type of vaccination - the so-called anti-vaxxers - it was immediately clear to behavioral … [Read more...]
Telehealth Is Here to Stay
OPYS Telehealth Blog Series December 2021 Issue No. 1 Telehealth is here to stay. There, I said it. While many people may not have heard the term ‘telemedicine’ prior to the COVID-19 worldwide pandemic, the terms ‘virtual health’, ‘virtual visit’, and ‘video visit’ are now commonly used to describe a telehealth visit; also known as a live, … [Read more...]
Are Pregnant Women Willing to get Vaccinated for COVID-19?
When the COVID-19 vaccinations were first authorized for emergency use, there was significant debate around whether pregnant women should receive the vaccines. With a lack of adequate data, it was difficult for physicians to advise that pregnant women pursue vaccination. With initial data suggesting that the vaccine was not leading to any serious … [Read more...]